TriSalus Life Sciences (TLSI) EBITDA Margin (2022 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly EBITDA Margin of 94.52% for Q1 2026, down 1457.0% year-over-year from 6.97% in Q1 2025, and down 281.56% quarter-over-quarter from 24.77% in Q4 2025.
TriSalus Life Sciences (TLSI) EBITDA Margin (2022 - 2026) Analysis & Trends
TriSalus Life Sciences' EBITDA Margin history runs 5 years deep, the most recent figure standing at 94.52% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 1457.0% year-over-year to 94.52%; the TTM figure through Mar 2026 stood at 62.45% (up 3656.0% YoY), while the FY2025 annual figure was 59.68%, up 6320.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 94.52%, down from 24.77% in the prior quarter.
- The five-year high for EBITDA Margin was 24.77% in Q4 2025, with the low at 364.91% in Q4 2022.
- The 5-year median for EBITDA Margin is 118.91% (2024), against an average of 174.09%.
- The sharpest annual moves came in 2023 and 2024: EBITDA Margin plunged 15173 bps in 2023, then jumped 23957 bps in 2024.
- TriSalus Life Sciences' EBITDA Margin stood at 364.91% in 2022, then soared by 32 bps to 249.05% in 2023, then soared by 63 bps to 91.76% in 2024, then jumped by 73 bps to 24.77% in 2025, then tumbled by 282 bps to 94.52% in 2026.
- Business Quant data shows TLSI's EBITDA Margin at 94.52% in Q1 2026, 24.77% in Q4 2025, and 77.94% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 19.15% |
| 10 | TriSalus Life Sciences | 307.81 Mn | 261.52 Mn | 9.90 Mn | -86.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -86.03% |
| Mar 31, 2026 | -94.52% |
| Dec 31, 2025 | -24.77% |
| Sep 30, 2025 | -77.94% |
| Jun 30, 2025 | -65.39% |
| Mar 31, 2025 | -79.95% |
| Dec 31, 2024 | -91.76% |
| Sep 30, 2024 | -118.91% |
| Jun 30, 2024 | -111.00% |
| Mar 31, 2024 | -180.77% |
| Dec 31, 2023 | -249.05% |
| Sep 30, 2023 | -358.48% |
| Jun 30, 2023 | -247.92% |
| Mar 31, 2023 | -339.18% |
| Dec 31, 2022 | -364.91% |
| Sep 30, 2022 | -206.76% |